Despite supporting weight loss, GLP-1 therapy may lead to a loss in lean muscle mass from a decreased nutritional intake from a reduced appetite
RISE works out how much sleep debt you have each day
doi: 10.1016/j.mcn.2015.10.005 155 XuWYangYYuanGZhuWMaDHuS
Briefly, the initial small increase of SHs stimulates GH secretion in the early phase of puberty, whereas during late puberty, the further increase of SHs determines bone ossification and, therefore, the arrest of growth [18]
[30] While more research is needed, berberines potential to support metabolic health may offer benefits for individuals looking to maintain overall wellness
Moreover, last year a separate study showed that 91% of obese individuals receiving a weekly dose of 15 mg Tirzepatidea recently developed GLP-1R/GIPR dual agonist, lost 5% of their body mass with 36% of participants on the same dosage losing at least 25% ( While these data are astoundingwith yearly progress in efficacy, we should consider that around 9% of patients receiving these game-changer treatments (Table 1)
